Peptide YY: More than just an appetite regulator

Diabetologia

Volumn 57, Issue 9, 2014, Pages 1762-1769

  Persaud, Shanta J ^a   Bewick, Gavin A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; Beta cells; Diabetes; Islets; NPY receptors; Peptide YY; Proliferation; Review

Indexed keywords

NEUROPEPTIDE Y RECEPTOR; PEPTIDE YY; GLUCOSE; GASTROINTESTINAL HORMONE; NEUROPEPTIDE Y; PEPTIDE;

APOPTOSIS; APPETITE; BODY WEIGHT; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; GLUCOSE HOMEOSTASIS; HUMAN; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; ANIMAL; DIABETES MELLITUS; FOOD INTAKE; HOMEOSTASIS; METABOLISM; PHYSIOLOGY; BRAIN; CELL PROTECTION; GLUCONEOGENESIS; MEDICAL INFORMATION;

ANIMALS; APOPTOSIS; APPETITE REGULATION; CELL PROLIFERATION; DIABETES MELLITUS; GLUCOSE; HOMEOSTASIS; HUMANS; PEPTIDE YY;

EID: 84905581281     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3292-y     Document Type: Review

References (62)

1. Ryan EA, Paty BW, Senior PA, et al. (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54:2060-2069
2. Tatemoto K, Mutt V (1980) Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature 285:417-418
3. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR (1985) Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89:1070-1077
4. Grandt D, Schimiczek M, Beglinger C, et al. (1994) Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 51:151-159
5. Medeiros MD, Turner AJ (1994) Processing and metabolism of peptide-YY: pivotal roles of dipeptidylpeptidase-IV, aminopeptidase-P, and endopeptidase-24.11. Endocrinology 134:2088-2094
6. Glavas MM, Grayson BE, Allen SE, et al. (2008) Characterization of brainstem peptide YY (PYY) neurons. J Comp Neurol 506:194-210
7. Gelegen C, Chandarana K, Choudhury AI, et al. (2012) Regulation of hindbrain Pyy expression by acute food deprivation, prolonged caloric restriction, and weight loss surgery in mice. Am J Physiol Endocrinol Metab 303:E659-E668
8. Upchurch BH, Fung BP, Rindi G, Ronco A, Leiter AB (1996) Peptide YY expression is an early event in colonic endocrine cell differentiation: evidence from normal and transgenic mice. Development 122:1157-1163
9. Roth KA, Kim S, Gordon JI (1992) Immunocytochemical studies suggest two pathways for enteroendocrine cell differentiation in the colon. Am J Physiol 263:G174-G180
10. Batterham RL, Bloom SR (2003) The gut hormone peptide YY regulates appetite. Ann NY Acad Sci 994:162-168
11. Batterham RL, Cowley MA, Small CJ, et al. (2002) Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418:650-654
12. Challis BG, Pinnock SB, Coll AP, Carter RN, Dickson SL, O'Rahilly S (2003) Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochem Biophys Res Commun 311:915-919
13. Chelikani PK, Haver AC, Reidelberger RD (2005) Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats. Endocrinology 146:879-888
14. Vrang N, Madsen AN, Tang-Christensen M, Hansen G, Larsen PJ (2006) PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 291:R367-R375
15. Ghamari-Langroudi M, Colmers WF, Cone RD (2005) PYY3-36 inhibits the action potential firing activity of POMC neurons of arcuate nucleus through postsynaptic Y2 receptors. Cell Metab 2:191-199
16. Baraboi ED, Michel C, Smith P, Thibaudeau K, Ferguson AV, Richard D (2010) Effects of albumin-conjugated PYY on food intake: the respective roles of the circumventricular organs and vagus nerve. Eur J Neurosci 32:826-839
17. Savage AP, Adrian TE, Carolan G, Chatterjee VK, Bloom SR (1987) Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 28:166-170
18. Symersky T, Biemond I, Frolich M, Masclee AA (2005) Effect of peptide YY on pancreatico-biliary secretion in humans. Scand J Gastroenterol 40:944-949
19. La Sala MS, Hurtado MD, Brown AR, et al. (2013) Modulation of taste responsiveness by the satiation hormone peptide YY. FASEB J 27:5022-5033
20. Ali-Rachedi A, Varndell IM, Adrian TE, et al. (1984) Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas. Histochemistry 80:487-491
21. Bottcher G, Ahren B, Lundquist I, Sundler F (1989) Peptide YY: intrapancreatic localization and effects on insulin and glucagon secretion in the mouse. Pancreas 4:282-288
22. Bottcher G, Sjoberg J, Ekman R, Hakanson R, Sundler F (1993) Peptide YY in the mammalian pancreas: immunocytochemical localization and immunochemical characterization. Regul Pept 43:115-130
23. Suzuki A, Nakauchi H, Taniguchi H (2003) Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells. Proc Natl Acad Sci U S A 100:5034-5039
24. el-Salhy M, Grimelius L, Emson PC, Falkmer S (1987) Polypeptide YY- and neuropeptide Y-immunoreactive cells and nerves in the endocrine and exocrine pancreas of some vertebrates: an onto- and phylogenetic study. Histochem J 19:111-117
25. Jackerott M, Oster A, Larsson LI (1996) PYY in developing murine islet cells: comparisons to development of islet hormones, NPY, and BrdU incorporation. J Histochem Cytochem 44:809-817
26. Upchurch BH, Aponte GW, Leiter AB (1994) Expression of peptide YY in all four islet cell types in the developing mouse pancreas suggests a common peptide YY-producing progenitor. Development 120:245-252
27. Schonhoff S, Baggio L, Ratineau C, et al. (2005) Energy homeostasis and gastrointestinal endocrine differentiation do not require the anorectic hormone peptide YY. Mol Cell Biol 25:4189-4199
28. Larhammar D (1996) Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Regul Pept 65:165-174
29. Grandt D, Teyssen S, Schimiczek M, et al. (1992) Novel generation of hormone receptor specificity by amino terminal processing of peptide YY. Biochem Biophys Res Commun 186:1299-1306
30. Abbott CR, Small CJ, Kennedy AR, et al. (2005) Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain Res 1043:139-144
31. Koda S, Date Y, Murakami N, et al. (2005) The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 146:2369-2375
32. Abbott CR, Monteiro M, Small CJ, et al. (2005) The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 1044:127-131
33. Pellieux C, Sauthier T, Domenighetti A, et al. (2000) Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors. Proc Natl Acad Sci U S A 97:1595-1600
34. Yang K, Guan H, Arany E, Hill DJ, Cao X (2008) Neuropeptide Y is produced in visceral adipose tissue and promotes proliferation of adipocyte precursor cells via the Y1 receptor. FASEB J 22:2452-2464
35. Mannon PJ, Kanungo A, Mannon RB, Ludwig KA (1999) Peptide YY/neuropeptide Y Y1 receptor expression in the epithelium and mucosal nerves of the human colon. Regul Pept 83:11-19
36. Amisten S, Salehi A, Rorsman P, Jones PM, Persaud SJ (2013) An atlas and functional analysis of G-protein coupled receptors in human islets of Langerhans. Pharmacol Ther 139:359-391
37. Burcelin R, Brunner H, Seydoux J, Thorensa B, Pedrazzini T (2001) Increased insulin concentrations and glucose storage in neuropeptide Y Y1 receptor-deficient mice. Peptides 22:421-427
38. Morgan DG, Kulkarni RN, Hurley JD, et al. (1998) Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells. Diabetologia 41:1482-1491
39. Chandarana K, Gelegen C, Irvine EE, et al. (2013) Peripheral activation of the Y2-receptor promotes secretion of GLP-1 and improves glucose tolerance. Mol Metab 2:142-152
40. Sam AH, Gunner DJ, King A, et al. (2012) Selective ablation of peptide YY cells in adult mice reveals their role in beta cell survival. Gastroenterology 143:459-468
41. Boey D, Lin S, Karl T, et al. (2006) Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity. Diabetologia 49:1360-1370
42. Lundquist I, Sundler F, Ahren B, Alumets J, Hakanson R (1979) Somatostatin, pancreatic polypeptide, substance P, and neurotensin: cellular distribution and effects on stimulated insulin secretion in the mouse. Endocrinology 104:832-838
43. Nieuwenhuizen AG, Karlsson S, Fridolf T, Ahren B (1994) Mechanisms underlying the insulinostatic effect of peptide YY in mouse pancreatic islets. Diabetologia 37:871-878
44. Ahren B, Larsson H (1996) Peptide YY does not inhibit glucose-stimulated insulin secretion in humans. Eur J Endocrinol 134:362-365
45. van den Hoek AM, Heijboer AC, Corssmit EP, et al. (2004) PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet. Diabetes 53:1949-1952
46. Liu G, Arnaud-Dabernat S, Kritzik MR, Kayali AG, Zhang YQ, Sarvetnick N (2006) PYY in the expanding pancreatic epithelium. Endocrine 30:103-112
47. Kahan BW, Jacobson LM, Hullett DA, et al. (2003) Pancreatic precursors and differentiated islet cell types from murine embryonic stem cells: an in vitro model to study islet differentiation. Diabetes 52:2016-2024
48. Goldberg Y, Taimor G, Piper HM, Schluter KD (1998) Intracellular signaling leads to the hypertrophic effect of neuropeptide Y. Am J Physiol 275:C1207-C1215
49. Decressac M, Wright B, David B, et al. (2011) Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis. Hippocampus 21:233-238
50. Hansel DE, Eipper BA, Ronnett GV (2001) Neuropeptide Y functions as a neuroproliferative factor. Nature 410:940-944
51. Howell OW, Scharfman HE, Herzog H, Sundstrom LE, Beck-Sickinger A, Gray WP (2003) Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells. J Neurochem 86:646-659
52. Nie M, Selbie LA (1998) Neuropeptide Y Y-1 and Y-2 receptor-mediated stimulation of mitogen-activated protein kinase activity. Regul Pept 75-6:207-213
53. Mannon PJ, Mele JM (2000) Peptide YY Y1 receptor activates mitogen-activated protein kinase and proliferation in gut epithelial cells via the epidermal growth factor receptor. Biochem J 350:655-661
54. Mannon PJ (2002) Peptide YY as a growth factor for intestinal epithelium. Peptides 23:383-388
55. Mannon PJ, Mervin SJ, Sheriff-Carter KD (1994) Characterization of a Y1-preferring NPY/PYY receptor in HT-29 cells. Am J Physiol 267:G901-G907
56. Cho YR, Kim CW (2004) Neuropeptide Y promotes beta-cell replication via extracellular signal-regulated kinase activation. Biochem Biophys Res Commun 314:773-780
57. Thiriet N, Deng X, Solinas M, et al. (2005) Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum. J Neurosci 25:5273-5279
58. Wu YF, Li SB (2005) Neuropeptide Y expression in mouse hippocampus and its role in neuronal excitotoxicity. Acta Pharmacol Sin 26:63-68
59. Basu A, Sivaprasad U (2007) Protein kinase Cε makes the life and death decision. Cell Signal 19:1633-1642
60. Vona-Davis L, McFadden DW (2007) PYY and the pancreas: inhibition of tumor growth and inflammation. Peptides 28:334-338
61. Eizirik DL, Mandrup-Poulsen T (2001) A choice of death - the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44:2115-2133
62. Ueberberg S, Ziegler D, Schechinger W, et al. (2010) In vitro phage display in a rat beta cell line: a simple approach for the generation of a single-chain antibody targeting a novel beta cell-specific epitope. Diabetologia 53:1384-1394